Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Aliada Therapeutics Inc | -8.58% | 1.40bn |
Celsius Therapeutics Inc | 0.34% | 250.00m |
Cerevel Therapeutics Holdings Inc | 18.79% | 8.70bn |
ImmunoGen Inc | 23.99% | 10.22bn |
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 30 Jun 2024 | 406.67k | 0.00% |
BRAM - Bradesco Asset Management SA DTVMas of 30 Jun 2024 | 57.28k | 0.00% |
Daycoval Asset Management Administra��o de Recursos Ltda.as of 30 Jun 2024 | 4.56k | 0.00% |
XP Allocation Asset Management Ltda.as of 30 Jun 2024 | 2.03k | 0.00% |
More ▼
Data from 30 Jun 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.